Koers HedgePath Pharmaceuticals Inc
Aandelen
US42278K1025
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13-12-22 |
James McNulty
DFI | Director of Finance/CFO | 73 | 13-12-22 |
Amy M. McCord
LAW | General Counsel | - | 01-01-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Frank O'Donnell
CEO | Chief Executive Officer | 74 | 13-12-22 |
Samuel Sears
BRD | Director/Board Member | 80 | 02-08-13 |
Ronald Osman
BRD | Director/Board Member | 78 | 23-08-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,77% | 49,46 mld. | |
+1,00% | 42,58 mld. | |
+49,51% | 42,49 mld. | |
-5,26% | 29,09 mld. | |
+13,68% | 26,61 mld. | |
-22,99% | 18,64 mld. | |
+8,22% | 13,16 mld. | |
+32,41% | 12,55 mld. | |
+24,01% | 12,1 mld. |